Masoud Panjehpour
Overview
Explore the profile of Masoud Panjehpour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Panjehpour M, Overholt B, Phan M, Haydek J
Gastrointest Endosc
. 2005 Jan;
61(1):13-8.
PMID: 15672050
Background: Photodynamic therapy (PDT) may be used to ablate high-grade dysplasia/early stage cancer (HGD/T1) in patients with Barrett's esophagus. PDT may result in esophageal stricture. This nonrandomized, unblinded, dose de-escalation...
12.
Overholt B, Panjehpour M, Halberg D
Gastrointest Endosc
. 2003 Jul;
58(2):183-8.
PMID: 12872083
Background: Photodynamic therapy has been shown to eliminate Barrett's dysplasia. This report presents long-term follow-up data after photodynamic therapy of Barrett's esophagus with high-grade dysplasia, low-grade dysplasia, or early stage...
13.
Panjehpour M, Julius C, Phan M, Vo-Dinh T, Overholt S
Lasers Surg Med
. 2002 Nov;
31(5):367-73.
PMID: 12430156
Background And Objectives: Laser-induced fluorescence spectroscopy is a non-invasive technique previously used for detection of cancer in a variety of organ systems. The objective of this study was to determine...
14.
Panjehpour M, DeNovo R, Petersen M, Overholt B, Bower R, Rubinchik V, et al.
Lasers Surg Med
. 2002 Feb;
30(1):26-30.
PMID: 11857600
Background And Objective: Verteporfin is a new photosensitizer with short-term skin photosensitivity. The objective of this preclinical study was to find the light dose that effectively ablates canine esophageal mucosa...